Unicycive Therapeutics
UNCY
11 hedge funds and large institutions have $2.3M invested in Unicycive Therapeutics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
10% more funds holding
Funds holding: 10 → 11 (+1)
0.01% more ownership
Funds ownership: 0.73% → 0.75% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
24% less capital invested
Capital invested by funds: $3.02M → $2.3M (-$717K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$11.6K |
| 3 |
BlackRock
New York
|
+$11.5K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$50 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$72K |
| 2 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$57K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$33.1K |
| 4 |
FWM
Frontier Wealth Management
Kansas City,
Missouri
|
-$100 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NCM
1
Nantahala Capital Management
New Canaan,
Connecticut
| $1.42M | -$33.1K | -1,324 | -2% |
|
|
BOTOTLSJU
2
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
| $510K | – | – | – |
|
|
AC
3
Ayrton Capital
Westport,
Connecticut
| $158K | +$192K | +7,665 | New |
|
4
Geode Capital Management
Boston,
Massachusetts
| $53K | – | – | – |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $47K | +$56.8K | +2,270 | New |
|
|
FWM
6
Frontier Wealth Management
Kansas City,
Missouri
| $39K | -$100 | -4 | -0.2% |
|
|
7
BlackRock
New York
| $33K | +$11.5K | +461 | +40% |
|
|
TCM
8
Tandem Capital Management
Woodcliff Lake,
New Jersey
| $32K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $11K | +$11.6K | +465 | +750% |
|
|
10
Two Sigma Investments
New York
| – | -$72K | -2,555 | Closed |
|
|
SMH
11
Sanders Morris Harris
Houston,
Texas
| – | -$57K | -2,000 | Closed |
|
|
12
Bank of America
Charlotte,
North Carolina
| – | +$50 | +2 | New |
|
UNCY Hedge Fund Activity: Q4 2021 in Review
11 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Unicycive Therapeutics (UNCY) for Q4 2021, worth a combined $2.3M — down 24% from $3.02M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new UNCY positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $56.8K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $72K sold.
- 11 institutional investors held Unicycive Therapeutics (UNCY) as of Q4 2021, up from 10 in Q3 2021.
- Funds reported $2.3M of Unicycive Therapeutics stock for Q4 2021, down 24% quarter-over-quarter.
- 3 funds opened new Unicycive Therapeutics positions in Q4 2021 and 2 closed out, a net change of +1 holder.
- The largest Unicycive Therapeutics buyer in Q4 2021 was Vanguard Group, an estimated $56.8K added.
- The largest Unicycive Therapeutics seller in Q4 2021 was Two Sigma Investments, an estimated $72K sold.
Based on aggregated 13F filings for Q4 2021.